These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 932431)

  • 1. Divergent effects of cyclophosphamide administration on mononuclear killer cells: quantitative depletion of cell numbers versus qualitative suppression of functional capabilities.
    Hunninghake GW; Fauci AS
    J Immunol; 1976 Jul; 117(1):337-42. PubMed ID: 932431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative and qualitative effects of cyclophosphamide administration on circulating polymorphonuclear leucocytes.
    Hunninghake GW; Fauci AS
    Immunology; 1976 Jul; 31(1):139-44. PubMed ID: 1027718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological reactivity of the lung. IV. Effect of cyclophosphamide on alveolar macrophage cytotoxic effector function.
    Hunninghake GW; Fauci AS
    Clin Exp Immunol; 1977 Mar; 27(3):555-9. PubMed ID: 862243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals.
    Fauci AS; Balow JE; Pratt KR
    J Clin Invest; 1976 Apr; 57(4):826-35. PubMed ID: 947955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the relative cytotoxic effector cell capabilities and the proportions of cells bearing various surface markers in human tonsil and peripheral blood mononuclear cells.
    Hunninghake GW; Haynes BF; Parrillo JE; Fauci AS
    Clin Exp Immunol; 1978 Apr; 32(1):186-91. PubMed ID: 668191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic reactivity of the lung. III. Effects of corticosteroids on alveolar macrophage cytotoxic effector cell function.
    Hunninghake GW; Fauci AS
    J Immunol; 1977 Jan; 118(1):146-50. PubMed ID: 830745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased production of Kurloff cells and accompanying lymphocyte subset changes in immunized guinea-pigs treated with cyclophosphamide and cyclosporin A.
    Thomson AW; McPhee CA; Sewell HF
    Immunology; 1988 Mar; 63(3):477-82. PubMed ID: 3350582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.
    Shore SL; Melewicz FM; Gordon DS
    J Immunol; 1977 Feb; 118(2):558-66. PubMed ID: 190316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
    Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
    J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations.
    Balow JE; Hurley DL; Fauci AS
    J Clin Invest; 1975 Jul; 56(1):65-70. PubMed ID: 1095612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
    Zhu XL; Chen AF; Lin ZB
    J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of antibody-dependent cellular cytotoxicity and mitogen-induced cellular cytotoxicity effector cell function in patients with acute myelogenous leukemia in remission.
    Zighelboim J
    Cancer Res; 1979 Sep; 39(9):3357-62. PubMed ID: 314332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of mononuclear effector cells in human blood.
    Hersey P; Edwards A; Edwards J
    Clin Exp Immunol; 1976 Jan; 23(1):104-13. PubMed ID: 1083316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cyclophosphamide on the allergic contact reaction in guinea pig: dose effects and influence on peripheral blood.
    Anderson C; Groth O
    Acta Derm Venereol; 1985; 65(5):403-8. PubMed ID: 2416163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
    Richter M; Banerjee D; Sklar S
    Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of human B lymphocyte function by cyclophosphamide.
    Cupps TR; Edgar LC; Fauci AS
    J Immunol; 1982 Jun; 128(6):2453-7. PubMed ID: 6978904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of cytotoxic effector cells and antibody producing cells from human intestine.
    MacDermott RP
    Acta Chir Scand Suppl; 1985; 525():25-43. PubMed ID: 3875204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood.
    Freundlich B; Trinchieri G; Perussia B; Zurier RB
    J Immunol; 1984 Mar; 132(3):1255-60. PubMed ID: 6693767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC-restricted cytotoxic response of chicken T cells: expression, augmentation, and clonal characterization.
    Maccubbin DL; Schierman LW
    J Immunol; 1986 Jan; 136(1):12-6. PubMed ID: 2415611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
    Welsh RM; Haspel MV; Parker DC; Holmes KV
    J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.